Raman Tuli
Geriatric Medicine · Gaithersburg, MDNPI 1477742476
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 339 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 15.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $2,484 and has fallen 91.2% since, to $217 in 2025. Among geriatric medicine clinicians in MD with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 339 payments — averaging $24.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sunovion Pharmaceuticals Inc.$1K
- Novo Nordisk$1K
- Vanda Pharmaceuticals Inc.$980
- Gilead$672
- Novartis$537
- Johnson & Johnson$506
- plus $3K from 28 others
Across 1 payment — averaging $436.36 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- F. Hoffmann-la Roche AG$436
What the payments were for
- Food & beverage$8,416100%
- Education$200%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sunovion Pharmaceuticals Inc. | 71 | $1,288 |
| Novo Nordisk | 31 | $1,243 |
| Vanda Pharmaceuticals Inc. | 56 | $980 |
| Gilead | 11 | $672 |
| Novartis | 21 | $537 |
| Johnson & Johnson | 13 | $506 |
| Bayer | 8 | $343 |
| AbbVie(2 entities) | 16 | $332 |
| Acadia Pharmaceuticals Inc | 7 | $316 |
| Lilly USA, LLC | 17 | $312 |
| AstraZeneca | 19 | $304 |
| Pfizer | 12 | $247 |
| Amgen(2 entities) | 9 | $197 |
| Avanir Pharmaceuticals, Inc. | 11 | $170 |
| Apellis Pharmaceuticals, Inc. | 2 | $144 |
| E.r. Squibb & Sons, L.L.C. | 1 | $115 |
| Abbott | 1 | $104 |
| Otsuka America Pharmaceutical, Inc. | 2 | $102 |
| UCB, Inc. | 3 | $67 |
| Sumitomo Pharma America, Inc. | 6 | $59 |
| Sun Pharmaceutical Industries Inc. | 3 | $55 |
| Merck | 4 | $51 |
| Nevro Corp. | 2 | $44 |
| Astellas Pharma US Inc | 2 | $37 |
| Daiichi Sankyo Inc. | 2 | $36 |
| Lundbeck LLC | 1 | $28 |
| Boehringer Ingelheim | 1 | $24 |
| Therapeuticsmd, Inc. | 1 | $21 |
| Nestle Healthcare Nutrition Inc. | 1 | $20 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
| Ultragenyx Pharmaceutical Inc. | 1 | $18 |
| Alkermes, Inc. | 1 | $17 |
| Radius Health, Inc. | 1 | $17 |
| Medtronic | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,435 in reported general payments places this provider in the 90th percentile of 112 geriatric medicine providers in Maryland.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 97 | $41,093 |
| TivicayDolutegravir Sodium | 14 | $28,348 |
| DescovyEmtricitabine/Tenofov Alafenam | 12 | $27,959 |
| AptiomEslicarbazepine Acetate | 39 | $19,785 |
| TrulicityDulaglutide | 36 | $16,413 |
| NuedextaDextromethorphan Hbr/Quinidine | 32 | $16,353 |
| JardianceEmpagliflozin | 28 | $9,556 |
| GemtesaVibegron | 16 | $8,333 |
| XareltoRivaroxaban | 24 | $8,048 |
| MyrbetriqMirabegron | 26 | $6,802 |
| Lurasidone Hcl | 13 | $4,943 |
| Mirtazapine | 102 | $4,199 |
| Atorvastatin Calcium | 164 | $3,379 |
| SymbicortBudesonide/Formoterol Fumarate | 11 | $2,996 |
| Asenapine Maleate | 12 | $2,958 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $247 | $41,09397 claims |
| GileadDescovy | $672 | $27,95912 claims |
| Sunovion Pharmaceuticals Inc.Aptiom | $1,288 | $19,78539 claims |
| Lilly USA, LLCTrulicity | $312 | $16,41336 claims |
| Avanir Pharmaceuticals, Inc.Nuedexta | $170 | $16,35332 claims |
| Boehringer IngelheimJardiance | $24 | $9,55628 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $59 | $8,33316 claims |
| Johnson & JohnsonXarelto | $506 | $8,04824 claims |
| Astellas Pharma US IncMyrbetriq | $37 | $6,80226 claims |
| AstraZenecaSymbicort | $304 | $2,99611 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 112 geriatric medicine providers in Maryland.
Other geriatric medicine in Gaithersburg
- Sean LengBaltimore$412K
- Jocelyn El-SayedBaltimore$84K
- Joanne LynnChevy Chase$52K
- James LettRockville$33K
- Marcelino AlbuerneCatonsville$14K
- Lee MusherChevy Chase$13K
- Bruce LeffBaltimore$7K
- Robert CooperBaltimore$7K
- Cyrus HamidiLutherville Timonium$6K
- Esther OhBaltimore$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.